Literature DB >> 9317088

An unusual complication of immunosuppressive therapy in inflammatory bowel disease.

M Khatchatourian1, T L Seaton.   

Abstract

A 68-yr-old man with steroid refractory distal ulcerative colitis was treated with low-dose 6-mercaptopurine, and corticosteroids were successfully discontinued. He later presented with dyspnea and fever, was diagnosed with Pneumocystis carinii pneumonia by bronchoalveolar lavage, and died despite aggressive therapy. Serological tests for HIV were negative, and his white blood cell count was normal. This is the first report of P. carinii pneumonia complicating therapy of inflammatory bowel disease with 6-mercaptopurine. Although the mechanism is not entirely clear, 6-mercaptopurine appears to decrease cell-mediated immunity. Opportunistic infections such as P. carinii pneumonia should be added to the list of potential bronchopulmonary complications of antimetabolite immunosuppressive therapy of inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317088

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.

Authors:  Thomas G Cotter; Nicola Gathaiya; Jelena Catania; Edward V Loftus; William J Tremaine; Larry M Baddour; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn; Andrew H Limper; Darrell S Pardi
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-21       Impact factor: 11.382

2.  Predicting the need for colectomy in pediatric patients with ulcerative colitis.

Authors:  R A Falcone; L G Lewis; B W Warner
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

3.  Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease.

Authors:  Millie D Long; Francis A Farraye; Philip N Okafor; Christopher Martin; Robert S Sandler; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2013-04       Impact factor: 5.325

4.  Pneumocystis pneumonia during combined therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease.

Authors:  Soichi Itaba; Tsutomu Iwasa; Yojiro Sadamoto; Toshifumi Nasu; Tadashi Misawa; Koji Inoue; Hidehiko Shimokawa; Kazuhiko Nakamura; Ryoichi Takayanagi
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.487

5.  Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review.

Authors:  Sally J Lawrence; Manish Sadarangani; Kevan Jacobson
Journal:  Front Pediatr       Date:  2017-07-24       Impact factor: 3.418

Review 6.  A Rare Case of Ulcerative Colitis with Severe Pneumocystis jirovecii Pneumonia and Cytomegalovirus Colitis: A Case Report and Literature Review.

Authors:  Yusuke Watanabe; Kazunao Hayashi; Shuji Terai
Journal:  Intern Med       Date:  2021-08-06       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.